LATEST PRESS RELEASES

IntelGenx Appoints Tommy Kenny as Vice President, Intellectual Property and Legal Affairs, General Counsel

SAINT LAURENT, Quebec, Jan. 12, 2021 -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (β€œIntelGenx” or the β€œCompany”) today announced that its Board of Directors appointed Mr. Tommy Kenny as Vice President, Intellectual Property and Legal Affairs, General Counsel of IntelGenx Corp., the Company’s operating subsidiary. Mr. Kenny ha... Read More...

MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

MindMed to Commence Groundbreaking LSD Microdosing Study Evaluating Benefits on Neuroplasticity, Sleep, Cognitive Enhancement Variables and Immune System Response on the Human Body NEW YORK, Jan. 12, 2021 -- MindMed (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company today announced an innovative randomi... Read More...

NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2021) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), a psychedelic drug development company, is pleased to announce that it has engaged Dr. C. Laird Birmingham to consult with NeonMind to develop protocols for its Phase 2 Clinical Trial administering psilocybin to treat obe... Read More...

Mind Cure Signs LOI to Acquire an Ownership Interest in Psychedelic Treatment Center ATMA, Selected by Section 56 Exempt Patient for Psilocybin Therapy

The strategic partnership between Mind Cure and ATMA will bridge access to research locations for psychedelic drug research while providing patient data for iSTRYM, Mind Cure's digital therapeutics platform.VANCOUVER, BC, Jan. 12, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("Mind Cure" or the "Company") is pleased ... Read More...

BetterLife Provides Shareholder Update and 2021 Product Development Roadmap

VANCOUVER, Jan. 11, 2021 -- VANCOUVER, January 12, 2021 - BetterLife Pharma Inc. (β€œBetterLife” or the β€œCompany”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting-edge treatments in mental disorders and viral infections, is pleased to provide an overview of the Company’... Read More...

Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a life sciences company focused on psychedelic therapeutics, is pleased to announce that Adelia Therapeutics Inc. ("Adelia"), a wholly-controlled subsidiary of Cybin, has achieved the earn-out milestones for the period commencing November 15, 2020, as contemplated by the terms of a contrib... Read More...

KCSA Strategic Communications to Host Inaugural KCSA Psychedelics Investor Conference on January 26-27, 2021

Featuring presentations by eminent psychedelics companies and industry leaders including keynote speakers, Rick Doblin, MAPS and Amy Emerson, MAPS Public Benefit CorporationNEW YORK, Jan. 11, 2021 -- KCSA Strategic Communications, an integrated strategic communications firm specializing in public relations, investor relations and social m... Read More...

Entheon Biomedical Engages World Renowned Media Personality DJ Skee, AKA Scott Keeney, as Media Advisor

Vancouver, British Columbia--(Newsfile Corp. - January 11, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce that it has engaged Mr. Scott Keeney, to serve as a media advisor.In his role, Mr. ... Read More...

Innovative Tennant Decorative Stone Slurryβ„’ System by Tennant Coatings Elevates Epoxy Flooring with Groundbreaking Functional Benefits and New Luxury Look

CHICAGO, Jan. 11, 2021 -- Tennant Coatings, Inc., industry-leading manufacturer of commercial, institutional and industrial coating systems for concrete floors has launched the innovative new Tennant Decorative Stone SlurryTM System. This epoxy flooring advancement features a unique luxury aesthetic with stunning color saturation and stri... Read More...

Mountain Valley MD Holdings Announces Application for OTCQB Listing in U.S., Provides Update on Warrant Exercises

TORONTO, Jan. 11, 2021 - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) is pleased to announce that it has submitted an application to have its common shares listed for trading on the OTCQB market (the "OTCQB"), a U.S. trading platform that is operated by the OTC Markets Group in New York. The listing o... Read More...

Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

Englewood Cliffs, NJ, Jan. 11, 2021 -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, last week announced a licensing agreement with up-front payment valued at $1 Million. Β The license agreement (the β€œAgreement”) with Aikido Pharma Inc., (Nasdaq:AIKI) a li... Read More...

Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics

HIGHLIGHTSUsing Kernel’s technology, Cybin will be able to quantify brain activity in real time during psychedelic experiences. The absence of this data has been a limitation in the progression of new molecules targeting neurological disorders.Kernel’s technology opens new frontier in psychedelic therapeutics by acquiring longitudinal bra... Read More...

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer

MYCO Continues to Strengthen Board of Directors in Anticipation of Senior Exchange Listing RequirementsDENVER, Jan. 11, 2021 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (β€œMydecine” or the β€œCompany’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative ... Read More...

Lobe Sciences Announces Changes to Board of Directors

Appointment of Michael Petter to the Board brings another seasoned board member with strong industry, capital markets and strategic planning expertise.Vancouver, British Columbia--(Newsfile Corp. - January 8, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Mi... Read More...

Review of Bipolar Disorders Confirms Early Diagnosis and Treatment Can Improve Patient Quality of Life

VANCOUVER, BC, Jan. 8, 2021 - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announces the publication of an article led by Dr. Roger McIntyre, CEO of Champignon Brands Inc. The article – Bipolar Disorders – is published in one of the world's best-known and most reputable scientific journals in medicine - T... Read More...

COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc (Nasdaq: CMPS) (β€œCOMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental... Read More...

Correction: COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways establishes Centre of Excellence with Sheppard Prattto accelerate research and improve patient experience in mental health careLondon, UK – 8 January 2021COMPASS Pathways plc (Nasdaq: CMPS) (β€œCOMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, is ... Read More...

Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

VANCOUVER, BC, Jan. 7, 2021 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 90 dispensaries throughout Arizona, is pleased to provide an update on it... Read More...

Thoughtful Brands Announces Binding Letter of Intent for Reverse-Takeover of Franchise Cannabis

Franchise Cannabis, a leading European medical cannabis company, to complete public listing with strategic expansion into other cannabis markets.Combined company will be well positioned to expand product offerings and distribution channels in the US and Europe.VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Thoughtful Brands Inc. ("TBI") (... Read More...

Red Light Holland Announces Increase in Bought Deal Equity Financing to $8.5 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.TORONTO, Jan. 07, 2021 -- Red Light Holland Corp. (β€œRed Light Holland” or the β€œCompany”) (CSE:TRIP), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a premium brand of magic truffles to the leg... Read More...

Codebase Updates Blockchain Investment Strategy

VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Codebase Ventures Inc. ("Codebase") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces an update to its blockchain investment strategy.The Company's primary blockchain interest is in Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability. Arcology is progressing towa... Read More...

BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board

VANCOUVER, Jan. 07, 2021 -- January 7, 2021 - BetterLife Pharma Inc. (β€œBetterLife” or the β€œCompany”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce the formation of its Next Generation Psychedelic Research Advisory Board and appointment of highly experienced Ms. Hattie Wells as its first member... Read More...

Pure Extracts Now Listed on the OTC Markets Under the Symbol PRXTF

VANCOUVER, British Columbia, Jan. 07, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL)(OTC: PRXTF)(XFRA: A2QJAJ) (β€œPure Extracts” or the β€œCompany”), a plant-based extraction company is pleased to announce that the Company received trading approval from OTC Markets and is now trading on the OTC Market under the ticker symbol PRXTF.Pure... Read More...

MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand

Bolsters Cash on Hand to CAD $183.0m (USD $144.4m)NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Jan. 7, 2021 -- Mind Medicine (MindMed) Inc. (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ) ("MindMed") is pleased to announce that it has closed its previously announced bought deal short for... Read More...

IntelGenx Receives First Purchase Order For CBD Filmstrips From Heritage Cannabis

SAINT LAURENT, Quebec, Jan. 07, 2021 -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced the execution of a definitive supply agreement (the β€œAgreement”) with Heritage Cannabis Holdings (β€œHeritage”), an international medical cannabis licensed producer based in Toronto, Canada (CSE:CANN)(OTCMRKTS:HERTF), f... Read More...

Holy Crap Brands Inc. Confirms Overwhelming Shareholder Approval to be Acquired by Plant&Co. Brands Ltd. Pursuant to an Amalgamation

Toronto, Ontario--(Newsfile Corp. - January 7, 2021) - Plant&Co. Brands Ltd. (CSE: VEGN) (FSE: VGP) (OTC PINK: EURPF) ("Plant&Co."),Β a vertically integrated enterprise focused on the health and wellness sector, and Holy Crap Brands Inc. (β€œHoly Crap”) are pleased to announce that the Annual General and Special Meeting (β€œAGSM”) of H... Read More...

Mydecine Innovations Group Shares Intellectual Property Update

Company files seven provisional patent applications with United States Patent and Trademark OfficeDENVER, Jan. 07, 2021 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA (β€œMydecine” or the β€œCompany’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative natur... Read More...

Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders

The MAPS-sponsored multi-site study will be the first of its kind assessing the viability of MDMA-assisted therapy to treat eating disorders, including Anorexia Nervosa and Binge Eating Disorder.TORONTO, Jan. 07, 2021 -- Field Trip Health Ltd. (CSE: FTRP) (OTCBB: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedel... Read More...

Empower Clinics KAI Medical Laboratory Sells Out First 5,000 Units Of FDA EUA Approved Saliva COVID-19 Test Kits. Issues Order For Next 25,000 KAI Saliva PCR Test Kits With Sales Value Of $5.5M. Discussions With Major Airlines Underway

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas,TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company's COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and collegesVANCOUVER, BC / ACCESSWIRE / January 7, 2021 / EMPOWER ... Read More...

Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs

VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce the appointment of Dr. Robert E.W. Hancock as Executive Chairman of the Company, effective January 6, 2021.Dr. Hancock is an internationally renowned academic in Mi... Read More...

Pure Extracts Technologies Closes $3 Million Lead Order and Announces Upsizing of Private Placement to $5 Million to Accommodate Investor Demand

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States.VANCOUVER, British Columbia, Jan. 06, 2021 -- Pure Extracts Technologies Corp. (β€œPure” or the β€œCompany”) (CSE: PULL)(XFRA: A2QJAJ) is pleased to annou... Read More...